Quintiles and DaVita Clinical Research announce strategic alliance

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/ernardaSv)
(Image: iStock/ernardaSv)

Related tags: Davita clinical research, Contract research organization, Clinical trial

The strategic alliance between Quintiles and the contract research organization (CRO) DaVita Clinical Research will focus on optimizing renal clinical trials.

Quintiles and DaVita Clinical Research have entered into a global strategic alliance to deliver a differentiated clinical trial offering (Phase II-IV) to biopharmaceutical customers in renal disease trials​,” Jeanne Hecht, SVP and Global Head, Site & Patient Networks at Quintiles, told Outsourcing-Pharma.com.

Through the alliance, Quintiles will gain access to DaVita’s clinical care experience and research sites.

By leveraging Quintiles’ protocol modeling and feasibility, in combination with DaVita Clinical Research’s extensive patient understanding, biopharmaceutical customers will be able to leverage the combined assets of both companies to progress their clinical programs​,” said Hecht.

Additionally, Hecht said that aligned operational procedures and historical site performance metrics will enable faster site start-up and more predictable patient enrollment.

Nephrology clinical studies can pose a series of challenges from progressively complex protocol designs to an increasing demand for broad patient population participation​,” added Hecht. “Through this alliance, we may also be able to alleviate the burden on patients participating in trials by incorporating clinical research into clinical care​.”

Related topics: Clinical Development, Phase III-IV

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars